PTX Pernix Therapeutics Holdings Inc.

2.90
+0.02  (1%)
Previous Close 2.88
Open 2.88
Price To book -0.23
Market Cap 33444027
Shares 11,532,423
Volume 29,798
Short Ratio 24.01
Av. Daily Volume 117,384

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approved May 15, 2015.
TREXIMET
Adolescent migraine patients

Latest News

  1. ETFs with exposure to Pernix Therapeutics Holdings, Inc. : November 17, 2017
  2. Pernix Therapeutics Announces Election of Two Healthcare Industry Veterans to Board of Directors
  3. Edited Transcript of PTX earnings conference call or presentation 7-Nov-17 9:30pm GMT
  4. Pernix Therapeutics Holdings, Inc. :PTX-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017
  5. Platinex Signs LOI to Acquire Interest in Cannabis-Infused Edible Brand and Co-Packing Facility in Oregon, Raising $600,000 in Private Placement - Video Hosted on InvestmentPitch.com
  6. Pernix Therapeutics Reports Third Quarter 2017 Financial Results
  7. Pernix Therapeutics Holdings, Inc. to Host Earnings Call
  8. Pernix Therapeutics Announces Sale of Non-Core Product
  9. Who Are The Largest Shareholders In Pernix Therapeutics Holdings Inc (PTX)?
  10. Pernix Therapeutics to Report Third Quarter 2017 Financial Results on Tuesday, November 7
  11. Pernix Therapeutics Announces Planned Departure of Chief Financial Officer
  12. ETFs with exposure to Pernix Therapeutics Holdings, Inc. : October 17, 2017
  13. ETFs with exposure to Pernix Therapeutics Holdings, Inc. : August 18, 2017
  14. Edited Transcript of PTX earnings conference call or presentation 27-Jul-17 8:30pm GMT
  15. Pernix Therapeutics Holdings, Inc. :PTX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 1, 2017
  16. Investor Network: Pernix Therapeutics Holdings, Inc. to Host Earnings Call

SEC Filings

  1. S-8 - Securities to be offered to employees in employee benefit plans 171214189
  2. 8-K - Current report 171205741
  3. 10-Q - Quarterly report [Sections 13 or 15(d)] 171184012
  4. DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material 171183360
  5. 8-K - Current report 171183343
  6. 8-K - Current report 171140837
  7. DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material 171104781
  8. DEF 14A - Other definitive proxy statements 171104762
  9. 8-K - Current report 171097843
  10. 8-K - Current report 171034091